Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Dr. Reddy's Laboratories Ltd Common Stock
(NY:
RDY
)
14.10
-0.39 (-2.69%)
Streaming Delayed Price
Updated: 10:50 AM EDT, Jul 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dr. Reddy's Laboratories Ltd Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Stocks That Hit 52-Week Lows On Tuesday
↗
March 01, 2022
During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the...
Via
Benzinga
Putin on the brink
↗
February 28, 2022
For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott.
Via
Talk Markets
Red Ink
↗
February 24, 2022
There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph
Via
Talk Markets
Give peace a chance
↗
February 15, 2022
Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today.
Via
Talk Markets
Dr. Reddy's Laboratories Announces the Launch of Its Authorized Generic Version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market
February 09, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
NYSE-Listed Pharma Co. Dr. Reddy's To Acquire German Medical Cannabis Firm Nimbus Health GmbH
↗
February 04, 2022
Pharmaceutical company Dr. Reddy's Laboratories Ltd. (NYSE:RDY) has entered into a definitive agreement to acquire Nimbus Health GmbH, a medical cannabis-focused licensed pharmaceutical wholesaler from...
Via
Benzinga
Weakened Tech Stocks
↗
February 03, 2022
There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks.
Via
Talk Markets
Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH
February 03, 2022
From
Dr. Reddy's Laboratories Ltd.
Via
Business Wire
Dr. Reddy’s Included in S&P Global’s Sustainability Yearbook for the 2nd Year and Bloomberg Gender-Equality Index for the 5th Year in a Row
February 02, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
The Last Day In January
↗
January 31, 2022
The market is suspicious of the moves up to right matters.
Via
Talk Markets
Earnings Scheduled For January 28, 2022
↗
January 28, 2022
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its third quarter. • LyondellBasell Industries (NYSE:...
Via
Benzinga
Reddy's To Launch Generic Version Of Merck's COVID-19 Drug At $0.50/Pill: Reuters
↗
January 04, 2022
India-based Dr Reddy's Laboratories Ltd (NYSE: RDY) will launch its generic version of Merck Co & Inc's (NYSE: MRK) COVID-19 antiviral pill, ...
Via
Benzinga
Happy New Year - Sunday Edition
↗
January 02, 2022
Starting a new year - we look at tech, pharma and mining stocks and their goings-on.
Via
Talk Markets
Market Trend: Erratic And Unreliable
↗
December 29, 2021
Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is.
Via
Talk Markets
A Bit Of Good News
↗
December 22, 2021
US growth figures for Q3 were up from forecasts of 2.1% at 2.3% but well down from the prior quarter level of 6.7%.
Via
Talk Markets
Dr. Reddy's Laboratories Announces the Launch of Venlafaxine ER Tablets in the U.S. Market
December 09, 2021
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories Announces the Launch of Valsartan Tablets, USP in the U.S. Market
December 09, 2021
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia
December 08, 2021
From
Prestige BioPharma Ltd.
Via
Business Wire
5 Reasons Why Sensex Crashed, Tarsons Products' Lukewarm Debut, And Buzzing Stocks Today
↗
November 29, 2021
Indian share markets, which ended deep in the red on Friday, are headed for a gap-up opening today following the trend on SGX Nifty.
Via
Talk Markets
Tuesday Market Overview
↗
November 16, 2021
While gold gained modestly again today, cryptocurrencies fell hard.
Via
Talk Markets
Dr. Reddy's Ready To Make COVID-19 Antiviral From Pfizer - Reuters
↗
November 16, 2021
Dr. Reddy's Laboratories Ltd (NYSE: RDY) said it was open to making Pfizer Inc's (NYSE: PFE) COVID-19 antiviral pill, Reuters reported. The new drugs can...
Via
Benzinga
Dr. Reddy's Laboratories Announces the Launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market
October 29, 2021
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Wednesday Market Coverage
↗
October 20, 2021
Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal.
Via
Talk Markets
Bitcoin Futures Arrive
↗
October 19, 2021
Today you can finally hold Bitcoins via an exchange-traded fund.
Via
Talk Markets
The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio
↗
October 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Entasis Announces Positive Data For Late-Stage Study Of SUL-DUR In...
Via
Benzinga
Dr. Reddy's Laboratories Announces Approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)
October 19, 2021
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection, USP in the U.S. Market
October 15, 2021
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Indian Study Shows Merck's COVID-19 Antiviral Candidate Less Effective Against Moderate Infection: Reuters
↗
October 08, 2021
According to a source with the Drug Controller General of India, Merck & Co Inc's (NYSE: MRK) antiviral drug molnupiravir has not shown "significant...
Via
Benzinga
A Bit Of A Recovery
↗
September 29, 2021
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.
Via
Talk Markets
Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential
↗
September 10, 2021
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
